- Research works
- 46 ▲ 79% vs 2013–17
- Citations
- 598 13.0 per fractional work
- Top-10% rate
- 5.4% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Rentschler Biopharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 20.1×. Every wedge is a field page.
Which keywords describe research at Rentschler Biopharma (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Cell Culture, Monoclonal Antibodies, Therapeutic Antibodies, Mammalian Cells, Recombinant Protein, Biopharmaceuticals and Immunogenicity.
- Translational Medicine
- Paul Ehrlich
- Imatinib
- BCR-ABL
- Chemotherapy
- Mutation
- Bioprinting
- Pediatric Pharmacokinetics
- Clinical Trials
- Regenerative Medicine
- Inflammation
- Immune Response
- Autoantibodies
- Epidemiology
- Gene Therapy
- Recombinant Proteins
- Immunogenicity
- Recombinant Protein
- Therapeutic Antibodies
- Cell Culture
- Glycosylation
- Monoclonal Antibodies
- Mammalian Cells
- Biopharmaceuticals
- Protein Aggregation
- Tissue Engineering
- Antibody Engineering
- Fc Receptors
- Method Validation
- Green Analytical Chemistry
- Pharmaceutical Analysis
- Vaccine
- Off-Label Drug Use
- Pharmacology
- Microfluidic Devices
- Quality of Life
- Airway Stenosis
- Cancer
- Management
- Tracheostomy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation8▲ 78×3 topics
- Cell Culture7▲ 134×2 topics
- Monoclonal Antibodies6▲ 89×3 topics
- Therapeutic Antibodies6▲ 97×2 topics
- Mammalian Cells6▲ 310×1 topic
- Recombinant Protein6▲ 310×1 topic
- Biopharmaceuticals4▲ 119×2 topics
- Immunogenicity4▲ 158×2 topics
- Protein Aggregation4▲ 99×1 topic
- Recombinant Proteins4▲ 148×1 topic
- Tissue Engineering2▲ 10×3 topics
- Gene Therapy2▲ 19×4 topics
- Antibody Engineering2▲ 46×1 topic
- Epidemiology2◆ 1.13×9 topics
- Fc Receptors2▲ 46×1 topic
- Autoantibodies2▲ 18×6 topics
- Method Validation2▲ 57×2 topics
- Immune Response2▲ 6.9×6 topics
- Green Analytical Chemistry2▲ 39×1 topic
- Inflammation2▲ 1.54×5 topics
- Pharmaceutical Analysis2▲ 118×1 topic
- Regenerative Medicine2▲ 15×2 topics
- Vaccine2▲ 8.1×5 topics
- Clinical Trials1▲ 5.0×2 topics
- Off-Label Drug Use1▲ 78×1 topic
- Pediatric Pharmacokinetics1▲ 78×1 topic
- Pharmacology1▲ 8.8×2 topics
- Bioprinting1▲ 57×1 topic
- Microfluidic Devices1▲ 31×1 topic
- Mutation1▲ 16×2 topics
- Quality of Life1▲ 1.88×3 topics
- Chemotherapy1▲ 3.4×3 topics
- Airway Stenosis1▲ 33×1 topic
- BCR-ABL1▲ 78×1 topic
- Cancer1▲ 1.63×4 topics
- Imatinib1▲ 78×1 topic
- Management1▲ 3.0×3 topics
- Paul Ehrlich1▲ 392×1 topic
- Tracheostomy1▲ 33×1 topic
- Translational Medicine1▲ 392×1 topic
Which research topics does Rentschler Biopharma (Germany) publish most on?
By volume in 2022–2025: Protein purification and stability, Microfluidic and Capillary Electrophoresis Applications, Viral Infectious Diseases and Gene Expression in Insects and Inhalation and Respiratory Drug Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein purification and stability Molecular Biology 1 works
- 2 Microfluidic and Capillary Electrophoresis Applications Biomedical Engineering 1 works
- 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 4 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
- 5 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 6 3D Printing in Biomedical Research Biomedical Engineering 0 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 8 Analytical Chemistry and Chromatography Spectroscopy 0 works
- 9 Virus-based gene therapy research Genetics 0 works
- 10 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Rentschler Biopharma (Germany)'s research output changed?
Output in 2018–2022 was 79% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.